Sumitomo Mitsui Trust Holdings, Inc. Care Dx, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,498,018 shares of CDNA stock, worth $33.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,498,018
Previous 1,653,927
9.43%
Holding current value
$33.8 Million
Previous $51.6 Million
37.89%
% of portfolio
0.02%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$102 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$70.9 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$67.4 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$45.9 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.21B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...